Novel Adaptive Cognitive Training in Autistic Adults with Co-occurring Insomnia

Description

The proposed study will test the usability and feasibility of a novel cognitive training (COGMUSE) for autistic adults with co-occurring insomnia (COGMUSE- AUT). Participants (n=15) will complete the cognitive training intervention for 60 minutes per day, 3 times per week for 6 weeks at home totaling to 18 hours. Weekly check-ins will be conducted by study staff over Teams to ensure adherence to the treatment and provide an opportunity for qualitative feedback on the game sessions played. During these 6 weeks, participants will fill out daily (2x/day) electronic sleep diaries and wear an actigraph device (GENEActiv). GENEActiv is a watch-like device that monitors light and movement activity.

Conditions

Autism Spectrum Disorder, Insomnia

Talk to us

Study Overview

On this page

Study Details

Study overview

The proposed study will test the usability and feasibility of a novel cognitive training (COGMUSE) for autistic adults with co-occurring insomnia (COGMUSE- AUT). Participants (n=15) will complete the cognitive training intervention for 60 minutes per day, 3 times per week for 6 weeks at home totaling to 18 hours. Weekly check-ins will be conducted by study staff over Teams to ensure adherence to the treatment and provide an opportunity for qualitative feedback on the game sessions played. During these 6 weeks, participants will fill out daily (2x/day) electronic sleep diaries and wear an actigraph device (GENEActiv). GENEActiv is a watch-like device that monitors light and movement activity.

COGMUSE-AUT: Novel Adaptive Cognitive Training in Autistic Adults with Co-occurring Insomnia

Novel Adaptive Cognitive Training in Autistic Adults with Co-occurring Insomnia

Condition
Autism Spectrum Disorder
Intervention / Treatment

-

Contacts and Locations

Tampa

University of South Florida, Tampa, Florida, United States, 33620

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. 18+ years of age
  • 2. Diagnosed with ASD (see 2a).
  • 3. Verbal IQ \>= 70 (Measured via the Weschler Abbreviated Scale of Intelligence 2nd Edition28); to ensure verbal skills sufficient to participate in treatment
  • 4. Able to undergo actigraphy assessment
  • 5. Can read and understand English
  • 6. Diagnosed with insomnia (See 3a).
  • 7. No prescribed or OTC sleep medications for 1+ month, or stabilized on medications for 6+ weeks.
  • 1. unable to provide informed consent
  • 2. diagnosis of sleep disorder other than insomnia \[i.e., sleep apnea (apnea/hypopnea index, AHI \>15), Periodic Limb Movement Disorder (myoclonus arousals per hour \>15)\],
  • 3. comorbid bipolar or seizure disorder (due to risk of sleep restriction treatment)
  • 4. other major psychopathology except depression or anxiety (e.g., suicidal ideation/intent, psychotic disorders)
  • 5. severe untreated psychiatric comorbidity
  • 6. psychotropic or other medications (e.g., beta-blockers) that alter sleep
  • 7. participation in non-pharmacological treatment (including CBT) for pain, sleep or mood outside current trial.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of South Florida,

Ashley F Curtis, PhD, PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

2025-04-01